nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—CYP3A5—Sulfasalazine—Crohn's disease	0.053	0.546	CbGbCtD
Temsirolimus—Alveolitis—Mesalazine—Crohn's disease	0.0295	0.0487	CcSEcCtD
Temsirolimus—ABCB1—Prednisone—Crohn's disease	0.0276	0.284	CbGbCtD
Temsirolimus—Eosinophilic pneumonia—Mesalazine—Crohn's disease	0.0225	0.0372	CcSEcCtD
Temsirolimus—Bilirubin total increased—Mesalazine—Crohn's disease	0.0184	0.0304	CcSEcCtD
Temsirolimus—CYP3A4—Prednisone—Crohn's disease	0.0165	0.17	CbGbCtD
Temsirolimus—Alveolitis allergic—Mesalazine—Crohn's disease	0.0142	0.0234	CcSEcCtD
Temsirolimus—Lacrimal structural disorder—Mesalazine—Crohn's disease	0.0126	0.0208	CcSEcCtD
Temsirolimus—Intestinal perforation—Azathioprine—Crohn's disease	0.0103	0.017	CcSEcCtD
Temsirolimus—Pericardial effusion—Mesalazine—Crohn's disease	0.00902	0.0149	CcSEcCtD
Temsirolimus—Bacterial infection—Azathioprine—Crohn's disease	0.0088	0.0145	CcSEcCtD
Temsirolimus—Rash generalised—Mesalazine—Crohn's disease	0.0087	0.0144	CcSEcCtD
Temsirolimus—Interstitial pneumonia—Azathioprine—Crohn's disease	0.0084	0.0139	CcSEcCtD
Temsirolimus—Lacrimal disorder—Mesalazine—Crohn's disease	0.00827	0.0137	CcSEcCtD
Temsirolimus—Prurigo—Mesalazine—Crohn's disease	0.00801	0.0132	CcSEcCtD
Temsirolimus—Interstitial pneumonia—Mesalazine—Crohn's disease	0.00765	0.0126	CcSEcCtD
Temsirolimus—Glucose tolerance impaired—Prednisone—Crohn's disease	0.00727	0.012	CcSEcCtD
Temsirolimus—Candida infection—Mercaptopurine—Crohn's disease	0.00651	0.0107	CcSEcCtD
Temsirolimus—Platelet count decreased—Mesalazine—Crohn's disease	0.00622	0.0103	CcSEcCtD
Temsirolimus—Mouth ulceration—Mercaptopurine—Crohn's disease	0.00616	0.0102	CcSEcCtD
Temsirolimus—Sepsis—Mercaptopurine—Crohn's disease	0.00591	0.00977	CcSEcCtD
Temsirolimus—Interstitial lung disease—Azathioprine—Crohn's disease	0.00574	0.00948	CcSEcCtD
Temsirolimus—Nail disorder—Mesalazine—Crohn's disease	0.0057	0.00942	CcSEcCtD
Temsirolimus—Herpes zoster—Azathioprine—Crohn's disease	0.00539	0.00891	CcSEcCtD
Temsirolimus—Lung disorder—Mesalazine—Crohn's disease	0.00523	0.00863	CcSEcCtD
Temsirolimus—Interstitial lung disease—Mesalazine—Crohn's disease	0.00523	0.00863	CcSEcCtD
Temsirolimus—Blood potassium decreased—Prednisone—Crohn's disease	0.00515	0.0085	CcSEcCtD
Temsirolimus—MTOR—epithelium—Crohn's disease	0.00501	0.0803	CbGeAlD
Temsirolimus—Pleural effusion—Mesalazine—Crohn's disease	0.00483	0.00798	CcSEcCtD
Temsirolimus—MTOR—smooth muscle tissue—Crohn's disease	0.00483	0.0773	CbGeAlD
Temsirolimus—MTOR—skin of body—Crohn's disease	0.00477	0.0763	CbGeAlD
Temsirolimus—Feeling hot—Mesalazine—Crohn's disease	0.00471	0.00778	CcSEcCtD
Temsirolimus—Rash pustular—Mesalazine—Crohn's disease	0.00464	0.00766	CcSEcCtD
Temsirolimus—Impaired healing—Prednisone—Crohn's disease	0.00453	0.00747	CcSEcCtD
Temsirolimus—FKBP1A—epithelium—Crohn's disease	0.00451	0.0722	CbGeAlD
Temsirolimus—Acne—Mesalazine—Crohn's disease	0.0044	0.00726	CcSEcCtD
Temsirolimus—MTOR—mammalian vulva—Crohn's disease	0.00435	0.0696	CbGeAlD
Temsirolimus—FKBP1A—smooth muscle tissue—Crohn's disease	0.00434	0.0696	CbGeAlD
Temsirolimus—FKBP1A—skin of body—Crohn's disease	0.00429	0.0687	CbGeAlD
Temsirolimus—Rectal haemorrhage—Mesalazine—Crohn's disease	0.0041	0.00676	CcSEcCtD
Temsirolimus—Hypocalcaemia—Mesalazine—Crohn's disease	0.00404	0.00667	CcSEcCtD
Temsirolimus—Blood bilirubin increased—Mesalazine—Crohn's disease	0.00391	0.00646	CcSEcCtD
Temsirolimus—FKBP1A—mammalian vulva—Crohn's disease	0.00391	0.0626	CbGeAlD
Temsirolimus—Embolism venous—Prednisone—Crohn's disease	0.00388	0.00641	CcSEcCtD
Temsirolimus—MTOR—lymphoid tissue—Crohn's disease	0.00386	0.0618	CbGeAlD
Temsirolimus—Lymphopenia—Prednisone—Crohn's disease	0.00382	0.00632	CcSEcCtD
Temsirolimus—MTOR—digestive system—Crohn's disease	0.00381	0.0611	CbGeAlD
Temsirolimus—Stomatitis—Mercaptopurine—Crohn's disease	0.00372	0.00614	CcSEcCtD
Temsirolimus—Phosphatase alkaline increased—Mesalazine—Crohn's disease	0.0037	0.00611	CcSEcCtD
Temsirolimus—Cystitis noninfective—Mesalazine—Crohn's disease	0.00361	0.00597	CcSEcCtD
Temsirolimus—Cystitis—Mesalazine—Crohn's disease	0.00357	0.0059	CcSEcCtD
Temsirolimus—Candida infection—Mesalazine—Crohn's disease	0.00353	0.00583	CcSEcCtD
Temsirolimus—FKBP1A—lymphoid tissue—Crohn's disease	0.00347	0.0556	CbGeAlD
Temsirolimus—FKBP1A—digestive system—Crohn's disease	0.00343	0.0549	CbGeAlD
Temsirolimus—Hypertriglyceridaemia—Prednisone—Crohn's disease	0.00341	0.00563	CcSEcCtD
Temsirolimus—Bladder pain—Mesalazine—Crohn's disease	0.00334	0.00552	CcSEcCtD
Temsirolimus—Mouth ulceration—Mesalazine—Crohn's disease	0.00334	0.00552	CcSEcCtD
Temsirolimus—Ecchymosis—Mesalazine—Crohn's disease	0.00334	0.00552	CcSEcCtD
Temsirolimus—Febrile neutropenia—Prednisone—Crohn's disease	0.00325	0.00537	CcSEcCtD
Temsirolimus—Immune system disorder—Mercaptopurine—Crohn's disease	0.00309	0.00511	CcSEcCtD
Temsirolimus—Blood alkaline phosphatase increased—Mesalazine—Crohn's disease	0.00309	0.0051	CcSEcCtD
Temsirolimus—Eczema—Mesalazine—Crohn's disease	0.00299	0.00493	CcSEcCtD
Temsirolimus—Blood triglycerides increased—Prednisone—Crohn's disease	0.00299	0.00493	CcSEcCtD
Temsirolimus—Malnutrition—Mercaptopurine—Crohn's disease	0.00298	0.00492	CcSEcCtD
Temsirolimus—Dermatitis bullous—Mesalazine—Crohn's disease	0.00281	0.00464	CcSEcCtD
Temsirolimus—Anaemia—Mercaptopurine—Crohn's disease	0.00275	0.00455	CcSEcCtD
Temsirolimus—Gastrointestinal haemorrhage—Mesalazine—Crohn's disease	0.00269	0.00443	CcSEcCtD
Temsirolimus—Leukopenia—Mercaptopurine—Crohn's disease	0.00267	0.0044	CcSEcCtD
Temsirolimus—Face oedema—Mesalazine—Crohn's disease	0.00259	0.00428	CcSEcCtD
Temsirolimus—Arthralgia—Mercaptopurine—Crohn's disease	0.00254	0.00419	CcSEcCtD
Temsirolimus—Fungal infection—Prednisone—Crohn's disease	0.00253	0.00419	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00252	0.00416	CcSEcCtD
Temsirolimus—Blood creatinine increased—Mesalazine—Crohn's disease	0.00252	0.00415	CcSEcCtD
Temsirolimus—Abscess—Prednisone—Crohn's disease	0.00247	0.00409	CcSEcCtD
Temsirolimus—Dry skin—Mesalazine—Crohn's disease	0.00246	0.00407	CcSEcCtD
Temsirolimus—Oedema—Mercaptopurine—Crohn's disease	0.00243	0.00402	CcSEcCtD
Temsirolimus—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.00242	0.00399	CcSEcCtD
Temsirolimus—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00238	0.00393	CcSEcCtD
Temsirolimus—Petechiae—Prednisone—Crohn's disease	0.00238	0.00393	CcSEcCtD
Temsirolimus—Gastritis—Mesalazine—Crohn's disease	0.00238	0.00392	CcSEcCtD
Temsirolimus—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.00237	0.00391	CcSEcCtD
Temsirolimus—Skin disorder—Mercaptopurine—Crohn's disease	0.00236	0.0039	CcSEcCtD
Temsirolimus—Abdominal distension—Mesalazine—Crohn's disease	0.00234	0.00386	CcSEcCtD
Temsirolimus—Acne—Prednisone—Crohn's disease	0.00233	0.00384	CcSEcCtD
Temsirolimus—Influenza—Mesalazine—Crohn's disease	0.00232	0.00383	CcSEcCtD
Temsirolimus—Dysphagia—Mesalazine—Crohn's disease	0.00232	0.00383	CcSEcCtD
Temsirolimus—Anorexia—Mercaptopurine—Crohn's disease	0.00232	0.00383	CcSEcCtD
Temsirolimus—Pneumonia—Azathioprine—Crohn's disease	0.00229	0.00377	CcSEcCtD
Temsirolimus—Infestation—Azathioprine—Crohn's disease	0.00227	0.00375	CcSEcCtD
Temsirolimus—Infestation NOS—Azathioprine—Crohn's disease	0.00227	0.00375	CcSEcCtD
Temsirolimus—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.00225	0.00372	CcSEcCtD
Temsirolimus—Bronchitis—Mesalazine—Crohn's disease	0.00223	0.00369	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00222	0.00366	CcSEcCtD
Temsirolimus—MTOR—lymph node—Crohn's disease	0.00218	0.0349	CbGeAlD
Temsirolimus—Dysuria—Mesalazine—Crohn's disease	0.00217	0.00358	CcSEcCtD
Temsirolimus—Neutropenia—Mesalazine—Crohn's disease	0.00217	0.00358	CcSEcCtD
Temsirolimus—Viral infection—Prednisone—Crohn's disease	0.00217	0.00358	CcSEcCtD
Temsirolimus—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00216	0.00356	CcSEcCtD
Temsirolimus—Pollakiuria—Mesalazine—Crohn's disease	0.00214	0.00354	CcSEcCtD
Temsirolimus—Decreased appetite—Mercaptopurine—Crohn's disease	0.00211	0.00349	CcSEcCtD
Temsirolimus—Weight decreased—Mesalazine—Crohn's disease	0.0021	0.00347	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.0021	0.00347	CcSEcCtD
Temsirolimus—Pneumonia—Mesalazine—Crohn's disease	0.00208	0.00344	CcSEcCtD
Temsirolimus—Infestation—Mesalazine—Crohn's disease	0.00207	0.00342	CcSEcCtD
Temsirolimus—Infestation NOS—Mesalazine—Crohn's disease	0.00207	0.00342	CcSEcCtD
Temsirolimus—Hypercholesterolaemia—Prednisone—Crohn's disease	0.00207	0.00342	CcSEcCtD
Temsirolimus—Depression—Mesalazine—Crohn's disease	0.00206	0.00341	CcSEcCtD
Temsirolimus—Cataract—Prednisone—Crohn's disease	0.00206	0.0034	CcSEcCtD
Temsirolimus—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.00205	0.00339	CcSEcCtD
Temsirolimus—Renal failure—Mesalazine—Crohn's disease	0.00203	0.00336	CcSEcCtD
Temsirolimus—Stomatitis—Mesalazine—Crohn's disease	0.00202	0.00333	CcSEcCtD
Temsirolimus—Conjunctivitis—Mesalazine—Crohn's disease	0.00201	0.00332	CcSEcCtD
Temsirolimus—Urinary tract infection—Mesalazine—Crohn's disease	0.00201	0.00332	CcSEcCtD
Temsirolimus—Haematuria—Mesalazine—Crohn's disease	0.00197	0.00326	CcSEcCtD
Temsirolimus—FKBP1A—lymph node—Crohn's disease	0.00196	0.0314	CbGeAlD
Temsirolimus—Epistaxis—Mesalazine—Crohn's disease	0.00195	0.00322	CcSEcCtD
Temsirolimus—Sinusitis—Mesalazine—Crohn's disease	0.00194	0.00321	CcSEcCtD
Temsirolimus—Erythema multiforme—Azathioprine—Crohn's disease	0.00193	0.00318	CcSEcCtD
Temsirolimus—Body temperature increased—Mercaptopurine—Crohn's disease	0.00192	0.00317	CcSEcCtD
Temsirolimus—Rhinitis—Mesalazine—Crohn's disease	0.00186	0.00308	CcSEcCtD
Temsirolimus—Fluid retention—Prednisone—Crohn's disease	0.00186	0.00307	CcSEcCtD
Temsirolimus—Pharyngitis—Mesalazine—Crohn's disease	0.00184	0.00305	CcSEcCtD
Temsirolimus—Immune system disorder—Azathioprine—Crohn's disease	0.00184	0.00304	CcSEcCtD
Temsirolimus—Mediastinal disorder—Azathioprine—Crohn's disease	0.00184	0.00304	CcSEcCtD
Temsirolimus—Urinary tract disorder—Mesalazine—Crohn's disease	0.00183	0.00303	CcSEcCtD
Temsirolimus—Oedema peripheral—Mesalazine—Crohn's disease	0.00183	0.00302	CcSEcCtD
Temsirolimus—Chills—Azathioprine—Crohn's disease	0.00183	0.00302	CcSEcCtD
Temsirolimus—Connective tissue disorder—Mesalazine—Crohn's disease	0.00183	0.00301	CcSEcCtD
Temsirolimus—Urethral disorder—Mesalazine—Crohn's disease	0.00182	0.00301	CcSEcCtD
Temsirolimus—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00179	0.00296	CcSEcCtD
Temsirolimus—Ecchymosis—Prednisone—Crohn's disease	0.00177	0.00292	CcSEcCtD
Temsirolimus—Erythema multiforme—Mesalazine—Crohn's disease	0.00176	0.0029	CcSEcCtD
Temsirolimus—Eye disorder—Mesalazine—Crohn's disease	0.00174	0.00287	CcSEcCtD
Temsirolimus—Cardiac disorder—Mesalazine—Crohn's disease	0.00172	0.00285	CcSEcCtD
Temsirolimus—Sepsis—Prednisone—Crohn's disease	0.0017	0.00281	CcSEcCtD
Temsirolimus—Angiopathy—Mesalazine—Crohn's disease	0.00169	0.00278	CcSEcCtD
Temsirolimus—Immune system disorder—Mesalazine—Crohn's disease	0.00168	0.00277	CcSEcCtD
Temsirolimus—Mediastinal disorder—Mesalazine—Crohn's disease	0.00167	0.00277	CcSEcCtD
Temsirolimus—Chills—Mesalazine—Crohn's disease	0.00167	0.00275	CcSEcCtD
Temsirolimus—Diarrhoea—Mercaptopurine—Crohn's disease	0.00166	0.00275	CcSEcCtD
Temsirolimus—Thrombophlebitis—Prednisone—Crohn's disease	0.00164	0.00271	CcSEcCtD
Temsirolimus—Anaemia—Azathioprine—Crohn's disease	0.00164	0.00271	CcSEcCtD
Temsirolimus—Diabetes mellitus—Prednisone—Crohn's disease	0.00163	0.0027	CcSEcCtD
Temsirolimus—Mental disorder—Mesalazine—Crohn's disease	0.00163	0.00269	CcSEcCtD
Temsirolimus—Erythema—Mesalazine—Crohn's disease	0.00162	0.00267	CcSEcCtD
Temsirolimus—Leukopenia—Azathioprine—Crohn's disease	0.00159	0.00262	CcSEcCtD
Temsirolimus—Dysgeusia—Mesalazine—Crohn's disease	0.00158	0.00262	CcSEcCtD
Temsirolimus—Back pain—Mesalazine—Crohn's disease	0.00156	0.00258	CcSEcCtD
Temsirolimus—Vomiting—Mercaptopurine—Crohn's disease	0.00155	0.00255	CcSEcCtD
Temsirolimus—Rash—Mercaptopurine—Crohn's disease	0.00153	0.00253	CcSEcCtD
Temsirolimus—Dermatitis—Mercaptopurine—Crohn's disease	0.00153	0.00253	CcSEcCtD
Temsirolimus—Myalgia—Azathioprine—Crohn's disease	0.00151	0.0025	CcSEcCtD
Temsirolimus—Arthralgia—Azathioprine—Crohn's disease	0.00151	0.0025	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.0015	0.00248	CcSEcCtD
Temsirolimus—Anaemia—Mesalazine—Crohn's disease	0.00149	0.00247	CcSEcCtD
Temsirolimus—CYP3A5—digestive system—Crohn's disease	0.00149	0.0239	CbGeAlD
Temsirolimus—Angioedema—Mesalazine—Crohn's disease	0.00148	0.00244	CcSEcCtD
Temsirolimus—Leukopenia—Mesalazine—Crohn's disease	0.00145	0.00239	CcSEcCtD
Temsirolimus—Nausea—Mercaptopurine—Crohn's disease	0.00144	0.00239	CcSEcCtD
Temsirolimus—Infection—Azathioprine—Crohn's disease	0.00144	0.00238	CcSEcCtD
Temsirolimus—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.00142	0.00235	CcSEcCtD
Temsirolimus—Thrombocytopenia—Azathioprine—Crohn's disease	0.00142	0.00234	CcSEcCtD
Temsirolimus—Cough—Mesalazine—Crohn's disease	0.00141	0.00233	CcSEcCtD
Temsirolimus—Skin disorder—Azathioprine—Crohn's disease	0.00141	0.00232	CcSEcCtD
Temsirolimus—Hypertension—Mesalazine—Crohn's disease	0.0014	0.00231	CcSEcCtD
Temsirolimus—Myalgia—Mesalazine—Crohn's disease	0.00138	0.00227	CcSEcCtD
Temsirolimus—Arthralgia—Mesalazine—Crohn's disease	0.00138	0.00227	CcSEcCtD
Temsirolimus—Chest pain—Mesalazine—Crohn's disease	0.00138	0.00227	CcSEcCtD
Temsirolimus—Anxiety—Mesalazine—Crohn's disease	0.00137	0.00227	CcSEcCtD
Temsirolimus—Face oedema—Prednisone—Crohn's disease	0.00137	0.00227	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00137	0.00226	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00132	0.00218	CcSEcCtD
Temsirolimus—Oedema—Mesalazine—Crohn's disease	0.00132	0.00218	CcSEcCtD
Temsirolimus—Anaphylactic shock—Mesalazine—Crohn's disease	0.00132	0.00218	CcSEcCtD
Temsirolimus—Infection—Mesalazine—Crohn's disease	0.00131	0.00217	CcSEcCtD
Temsirolimus—Dry skin—Prednisone—Crohn's disease	0.0013	0.00215	CcSEcCtD
Temsirolimus—Nervous system disorder—Mesalazine—Crohn's disease	0.00129	0.00214	CcSEcCtD
Temsirolimus—Hypokalaemia—Prednisone—Crohn's disease	0.00129	0.00214	CcSEcCtD
Temsirolimus—Thrombocytopenia—Mesalazine—Crohn's disease	0.00129	0.00213	CcSEcCtD
Temsirolimus—Skin disorder—Mesalazine—Crohn's disease	0.00128	0.00212	CcSEcCtD
Temsirolimus—Anorexia—Mesalazine—Crohn's disease	0.00126	0.00208	CcSEcCtD
Temsirolimus—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.00125	0.00207	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00125	0.00207	CcSEcCtD
Temsirolimus—Abdominal distension—Prednisone—Crohn's disease	0.00124	0.00204	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.0012	0.00199	CcSEcCtD
Temsirolimus—Insomnia—Mesalazine—Crohn's disease	0.00119	0.00197	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00118	0.00196	CcSEcCtD
Temsirolimus—Dyspnoea—Mesalazine—Crohn's disease	0.00118	0.00194	CcSEcCtD
Temsirolimus—Somnolence—Mesalazine—Crohn's disease	0.00117	0.00194	CcSEcCtD
Temsirolimus—Neutropenia—Prednisone—Crohn's disease	0.00115	0.0019	CcSEcCtD
Temsirolimus—Decreased appetite—Mesalazine—Crohn's disease	0.00115	0.00189	CcSEcCtD
Temsirolimus—Abdominal pain—Azathioprine—Crohn's disease	0.00115	0.00189	CcSEcCtD
Temsirolimus—Body temperature increased—Azathioprine—Crohn's disease	0.00115	0.00189	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00114	0.00188	CcSEcCtD
Temsirolimus—Fatigue—Mesalazine—Crohn's disease	0.00114	0.00188	CcSEcCtD
Temsirolimus—Pain—Mesalazine—Crohn's disease	0.00113	0.00186	CcSEcCtD
Temsirolimus—Constipation—Mesalazine—Crohn's disease	0.00113	0.00186	CcSEcCtD
Temsirolimus—CYP3A4—digestive system—Crohn's disease	0.00112	0.0179	CbGeAlD
Temsirolimus—Weight decreased—Prednisone—Crohn's disease	0.00111	0.00183	CcSEcCtD
Temsirolimus—Hyperglycaemia—Prednisone—Crohn's disease	0.00111	0.00183	CcSEcCtD
Temsirolimus—CYP2D6—digestive system—Crohn's disease	0.0011	0.0177	CbGeAlD
Temsirolimus—Depression—Prednisone—Crohn's disease	0.00109	0.0018	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00108	0.00178	CcSEcCtD
Temsirolimus—Hypersensitivity—Azathioprine—Crohn's disease	0.00107	0.00176	CcSEcCtD
Temsirolimus—Body temperature increased—Mesalazine—Crohn's disease	0.00104	0.00172	CcSEcCtD
Temsirolimus—Abdominal pain—Mesalazine—Crohn's disease	0.00104	0.00172	CcSEcCtD
Temsirolimus—ABCB1—epithelium—Crohn's disease	0.00104	0.0167	CbGeAlD
Temsirolimus—Diarrhoea—Azathioprine—Crohn's disease	0.000991	0.00164	CcSEcCtD
Temsirolimus—Hypersensitivity—Mesalazine—Crohn's disease	0.000972	0.00161	CcSEcCtD
Temsirolimus—Connective tissue disorder—Prednisone—Crohn's disease	0.000966	0.0016	CcSEcCtD
Temsirolimus—Dizziness—Azathioprine—Crohn's disease	0.000958	0.00158	CcSEcCtD
Temsirolimus—Asthenia—Mesalazine—Crohn's disease	0.000947	0.00156	CcSEcCtD
Temsirolimus—Pruritus—Mesalazine—Crohn's disease	0.000934	0.00154	CcSEcCtD
Temsirolimus—Vomiting—Azathioprine—Crohn's disease	0.000921	0.00152	CcSEcCtD
Temsirolimus—Eye disorder—Prednisone—Crohn's disease	0.000919	0.00152	CcSEcCtD
Temsirolimus—Rash—Azathioprine—Crohn's disease	0.000914	0.00151	CcSEcCtD
Temsirolimus—Dermatitis—Azathioprine—Crohn's disease	0.000913	0.00151	CcSEcCtD
Temsirolimus—Headache—Azathioprine—Crohn's disease	0.000908	0.0015	CcSEcCtD
Temsirolimus—ABCB1—mammalian vulva—Crohn's disease	0.000905	0.0145	CbGeAlD
Temsirolimus—Diarrhoea—Mesalazine—Crohn's disease	0.000903	0.00149	CcSEcCtD
Temsirolimus—Angiopathy—Prednisone—Crohn's disease	0.000892	0.00147	CcSEcCtD
Temsirolimus—Immune system disorder—Prednisone—Crohn's disease	0.000888	0.00147	CcSEcCtD
Temsirolimus—Dizziness—Mesalazine—Crohn's disease	0.000873	0.00144	CcSEcCtD
Temsirolimus—Mental disorder—Prednisone—Crohn's disease	0.000861	0.00142	CcSEcCtD
Temsirolimus—Nausea—Azathioprine—Crohn's disease	0.000861	0.00142	CcSEcCtD
Temsirolimus—Erythema—Prednisone—Crohn's disease	0.000856	0.00141	CcSEcCtD
Temsirolimus—Malnutrition—Prednisone—Crohn's disease	0.000856	0.00141	CcSEcCtD
Temsirolimus—Vomiting—Mesalazine—Crohn's disease	0.000839	0.00139	CcSEcCtD
Temsirolimus—Rash—Mesalazine—Crohn's disease	0.000832	0.00137	CcSEcCtD
Temsirolimus—Dermatitis—Mesalazine—Crohn's disease	0.000831	0.00137	CcSEcCtD
Temsirolimus—Headache—Mesalazine—Crohn's disease	0.000827	0.00137	CcSEcCtD
Temsirolimus—ABCB1—lymphoid tissue—Crohn's disease	0.000803	0.0129	CbGeAlD
Temsirolimus—ABCB1—digestive system—Crohn's disease	0.000793	0.0127	CbGeAlD
Temsirolimus—Anaemia—Prednisone—Crohn's disease	0.000791	0.00131	CcSEcCtD
Temsirolimus—Nausea—Mesalazine—Crohn's disease	0.000784	0.00129	CcSEcCtD
Temsirolimus—Angioedema—Prednisone—Crohn's disease	0.000782	0.00129	CcSEcCtD
Temsirolimus—Convulsion—Prednisone—Crohn's disease	0.000741	0.00122	CcSEcCtD
Temsirolimus—Hypertension—Prednisone—Crohn's disease	0.000739	0.00122	CcSEcCtD
Temsirolimus—Arthralgia—Prednisone—Crohn's disease	0.000728	0.0012	CcSEcCtD
Temsirolimus—Myalgia—Prednisone—Crohn's disease	0.000728	0.0012	CcSEcCtD
Temsirolimus—Anxiety—Prednisone—Crohn's disease	0.000726	0.0012	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000723	0.00119	CcSEcCtD
Temsirolimus—Anaphylactic shock—Prednisone—Crohn's disease	0.000698	0.00115	CcSEcCtD
Temsirolimus—Oedema—Prednisone—Crohn's disease	0.000698	0.00115	CcSEcCtD
Temsirolimus—Infection—Prednisone—Crohn's disease	0.000694	0.00115	CcSEcCtD
Temsirolimus—Nervous system disorder—Prednisone—Crohn's disease	0.000685	0.00113	CcSEcCtD
Temsirolimus—Skin disorder—Prednisone—Crohn's disease	0.000678	0.00112	CcSEcCtD
Temsirolimus—Anorexia—Prednisone—Crohn's disease	0.000666	0.0011	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000636	0.00105	CcSEcCtD
Temsirolimus—Insomnia—Prednisone—Crohn's disease	0.000632	0.00104	CcSEcCtD
Temsirolimus—Decreased appetite—Prednisone—Crohn's disease	0.000607	0.001	CcSEcCtD
Temsirolimus—Fatigue—Prednisone—Crohn's disease	0.000602	0.000994	CcSEcCtD
Temsirolimus—Constipation—Prednisone—Crohn's disease	0.000597	0.000986	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Prednisone—Crohn's disease	0.000571	0.000943	CcSEcCtD
Temsirolimus—Abdominal pain—Prednisone—Crohn's disease	0.000552	0.000912	CcSEcCtD
Temsirolimus—Body temperature increased—Prednisone—Crohn's disease	0.000552	0.000912	CcSEcCtD
Temsirolimus—Hypersensitivity—Prednisone—Crohn's disease	0.000514	0.00085	CcSEcCtD
Temsirolimus—Asthenia—Prednisone—Crohn's disease	0.000501	0.000827	CcSEcCtD
Temsirolimus—Pruritus—Prednisone—Crohn's disease	0.000494	0.000816	CcSEcCtD
Temsirolimus—Diarrhoea—Prednisone—Crohn's disease	0.000478	0.000789	CcSEcCtD
Temsirolimus—FKBP1A—Signaling Pathways—TAGAP—Crohn's disease	0.000467	0.00199	CbGpPWpGaD
Temsirolimus—MTOR—Leptin signaling pathway—STAT3—Crohn's disease	0.000464	0.00198	CbGpPWpGaD
Temsirolimus—Dizziness—Prednisone—Crohn's disease	0.000462	0.000763	CcSEcCtD
Temsirolimus—CYP2D6—Metapathway biotransformation—GPX4—Crohn's disease	0.000456	0.00194	CbGpPWpGaD
Temsirolimus—ABCB1—lymph node—Crohn's disease	0.000453	0.00726	CbGeAlD
Temsirolimus—MTOR—Signaling by VEGF—JAK2—Crohn's disease	0.000449	0.00191	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by Insulin receptor—JAK2—Crohn's disease	0.000446	0.0019	CbGpPWpGaD
Temsirolimus—Vomiting—Prednisone—Crohn's disease	0.000444	0.000733	CcSEcCtD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—CXCL8—Crohn's disease	0.000441	0.00188	CbGpPWpGaD
Temsirolimus—Rash—Prednisone—Crohn's disease	0.00044	0.000727	CcSEcCtD
Temsirolimus—Dermatitis—Prednisone—Crohn's disease	0.00044	0.000726	CcSEcCtD
Temsirolimus—Headache—Prednisone—Crohn's disease	0.000437	0.000722	CcSEcCtD
Temsirolimus—ABCB1—Allograft Rejection—IL10—Crohn's disease	0.000436	0.00186	CbGpPWpGaD
Temsirolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—STAT3—Crohn's disease	0.000424	0.0018	CbGpPWpGaD
Temsirolimus—MTOR—CXCR4-mediated signaling events—STAT3—Crohn's disease	0.000424	0.0018	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—ICOSLG—Crohn's disease	0.000424	0.0018	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—IL1B—Crohn's disease	0.000423	0.0018	CbGpPWpGaD
Temsirolimus—Nausea—Prednisone—Crohn's disease	0.000415	0.000685	CcSEcCtD
Temsirolimus—FKBP1A—Signaling Pathways—RSPO3—Crohn's disease	0.000408	0.00174	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—IL6—Crohn's disease	0.000401	0.00171	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—TYK2—Crohn's disease	0.0004	0.0017	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—GCKR—Crohn's disease	0.0004	0.0017	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	0.000389	0.00165	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—SEL1L—Crohn's disease	0.000387	0.00165	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—NOD1—Crohn's disease	0.000386	0.00164	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—TYK2—Crohn's disease	0.000383	0.00163	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—JAK2—Crohn's disease	0.000382	0.00162	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—DEFA5—Crohn's disease	0.000378	0.00161	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IFNGR2—Crohn's disease	0.000378	0.00161	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—TYK2—Crohn's disease	0.000377	0.0016	CbGpPWpGaD
Temsirolimus—MTOR—BDNF signaling pathway—JAK2—Crohn's disease	0.000375	0.0016	CbGpPWpGaD
Temsirolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TNF—Crohn's disease	0.000367	0.00156	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—JAK2—Crohn's disease	0.000365	0.00155	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—TYK2—Crohn's disease	0.00036	0.00153	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—JAK2—Crohn's disease	0.00036	0.00153	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—TYK2—Crohn's disease	0.000358	0.00152	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—TYK2—Crohn's disease	0.000356	0.00152	CbGpPWpGaD
Temsirolimus—MTOR—ErbB1 downstream signaling—STAT3—Crohn's disease	0.000355	0.00151	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—TYK2—Crohn's disease	0.000355	0.00151	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CCR9—Crohn's disease	0.000354	0.00151	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—SLC11A1—Crohn's disease	0.000353	0.0015	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CCR6—Crohn's disease	0.00035	0.00149	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—JAK2—Crohn's disease	0.000343	0.00146	CbGpPWpGaD
Temsirolimus—MTOR—EGF/EGFR Signaling Pathway—JAK2—Crohn's disease	0.000342	0.00145	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—JAK2—Crohn's disease	0.000342	0.00145	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—JAK2—Crohn's disease	0.00034	0.00145	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—JAK2—Crohn's disease	0.000338	0.00144	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	0.000338	0.00144	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—TYK2—Crohn's disease	0.000334	0.00142	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—TYK2—Crohn's disease	0.000334	0.00142	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—TYK2—Crohn's disease	0.000334	0.00142	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—TYK2—Crohn's disease	0.000331	0.00141	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—GPR65—Crohn's disease	0.000329	0.0014	CbGpPWpGaD
Temsirolimus—MTOR—Disease—RSPO3—Crohn's disease	0.000328	0.0014	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—TYK2—Crohn's disease	0.000328	0.00139	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—TYK2—Crohn's disease	0.000326	0.00139	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—JAK2—Crohn's disease	0.000318	0.00135	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—JAK2—Crohn's disease	0.000318	0.00135	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—JAK2—Crohn's disease	0.000318	0.00135	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—JAK2—Crohn's disease	0.000315	0.00134	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—JAK2—Crohn's disease	0.000313	0.00133	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—JAK2—Crohn's disease	0.000311	0.00132	CbGpPWpGaD
Temsirolimus—MTOR—Disease—SEL1L—Crohn's disease	0.000311	0.00132	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CARD9—Crohn's disease	0.000308	0.00131	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—RBX1—Crohn's disease	0.000304	0.00129	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—ACKR2—Crohn's disease	0.000303	0.00129	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—HSPA1B—Crohn's disease	0.000303	0.00129	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—RBX1—Crohn's disease	0.000303	0.00129	CbGpPWpGaD
Temsirolimus—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	0.000298	0.00127	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—TYK2—Crohn's disease	0.000296	0.00126	CbGpPWpGaD
Temsirolimus—MTOR—IRS-mediated signalling—IL6—Crohn's disease	0.000293	0.00125	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MLN—Crohn's disease	0.000287	0.00122	CbGpPWpGaD
Temsirolimus—MTOR—IRS-related events—IL6—Crohn's disease	0.000285	0.00121	CbGpPWpGaD
Temsirolimus—MTOR—IRS-related events triggered by IGF1R—IL6—Crohn's disease	0.000283	0.0012	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—JAK2—Crohn's disease	0.000282	0.0012	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—STAT3—Crohn's disease	0.00028	0.00119	CbGpPWpGaD
Temsirolimus—MTOR—Disease—LTF—Crohn's disease	0.000279	0.00119	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—UBE2D1—Crohn's disease	0.000278	0.00118	CbGpPWpGaD
Temsirolimus—MTOR—BDNF signaling pathway—STAT3—Crohn's disease	0.000276	0.00117	CbGpPWpGaD
Temsirolimus—MTOR—Insulin receptor signalling cascade—IL6—Crohn's disease	0.000275	0.00117	CbGpPWpGaD
Temsirolimus—MTOR—IGF1R signaling cascade—IL6—Crohn's disease	0.000275	0.00117	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.000274	0.00117	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—RIPK2—Crohn's disease	0.000269	0.00115	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—UBE2D1—Crohn's disease	0.000267	0.00113	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—UBE2D1—Crohn's disease	0.000266	0.00113	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TAGAP—Crohn's disease	0.000263	0.00112	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—RIPK2—Crohn's disease	0.000259	0.0011	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—ITGA4—Crohn's disease	0.000259	0.0011	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IFNG—Crohn's disease	0.000256	0.00109	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—RASGRP1—Crohn's disease	0.000254	0.00108	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—STAT3—Crohn's disease	0.000252	0.00107	CbGpPWpGaD
Temsirolimus—MTOR—EGF/EGFR Signaling Pathway—STAT3—Crohn's disease	0.000251	0.00107	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—TAB1—Crohn's disease	0.000249	0.00106	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PLA2G4F—Crohn's disease	0.000248	0.00106	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—IL6—Crohn's disease	0.000248	0.00105	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000246	0.00104	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000246	0.00104	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—NOD2—Crohn's disease	0.000244	0.00104	CbGpPWpGaD
Temsirolimus—MTOR—VEGFA-VEGFR2 Pathway—IL6—Crohn's disease	0.000244	0.00104	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—RASGRP1—Crohn's disease	0.000244	0.00104	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD79A—Crohn's disease	0.000243	0.00103	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	0.000238	0.00101	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CCR6—Crohn's disease	0.000235	0.000998	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—STAT3—Crohn's disease	0.000234	0.000994	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by VEGF—IL6—Crohn's disease	0.00023	0.00098	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—SOCS1—Crohn's disease	0.00023	0.000979	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—RSPO3—Crohn's disease	0.00023	0.000977	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by Insulin receptor—IL6—Crohn's disease	0.000229	0.000974	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IL1B—Crohn's disease	0.000229	0.000973	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—STAT3—Crohn's disease	0.000229	0.000972	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—TYK2—Crohn's disease	0.000227	0.000967	CbGpPWpGaD
Temsirolimus—MTOR—Disease—GCKR—Crohn's disease	0.000225	0.000956	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—NOD1—Crohn's disease	0.000225	0.000956	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—SOCS1—Crohn's disease	0.000221	0.00094	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SEL1L—Crohn's disease	0.000218	0.000926	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—JAK2—Crohn's disease	0.000217	0.000923	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—RBX1—Crohn's disease	0.000212	0.000902	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—CXCL8—Crohn's disease	0.000211	0.000898	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—MTMR3—Crohn's disease	0.000211	0.000897	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—STAT3—Crohn's disease	0.000207	0.00088	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PTGER4—Crohn's disease	0.000207	0.000879	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CCR6—Crohn's disease	0.000204	0.000868	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCR9—Crohn's disease	0.000199	0.000847	CbGpPWpGaD
Temsirolimus—MTOR—Disease—SLC11A1—Crohn's disease	0.000199	0.000845	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—IL6—Crohn's disease	0.000196	0.000833	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—SMAD3—Crohn's disease	0.00019	0.000808	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—IL6—Crohn's disease	0.000187	0.000797	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—PTPN2—Crohn's disease	0.000187	0.000794	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—UBE2D1—Crohn's disease	0.000186	0.000791	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—GPR65—Crohn's disease	0.000185	0.000788	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—RBX1—Crohn's disease	0.000185	0.000785	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—IL6—Crohn's disease	0.000184	0.000784	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—RIPK2—Crohn's disease	0.00018	0.000767	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PLA2G4F—Crohn's disease	0.000179	0.000763	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—IL6—Crohn's disease	0.000176	0.000749	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL3—Crohn's disease	0.000176	0.000748	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—IL6—Crohn's disease	0.000175	0.000745	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—IL6—Crohn's disease	0.000174	0.000742	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CRP—Crohn's disease	0.000174	0.000739	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—IL6—Crohn's disease	0.000173	0.000738	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000173	0.000736	CbGpPWpGaD
Temsirolimus—MTOR—Disease—RBX1—Crohn's disease	0.00017	0.000725	CbGpPWpGaD
Temsirolimus—MTOR—Disease—HSPA1B—Crohn's disease	0.00017	0.000725	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—RASGRP1—Crohn's disease	0.00017	0.000724	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—STAT3—Crohn's disease	0.00017	0.000722	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—TLR4—Crohn's disease	0.000166	0.000708	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—TNF—Crohn's disease	0.000166	0.000706	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—FADS1—Crohn's disease	0.000164	0.000699	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—IL6—Crohn's disease	0.000163	0.000694	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—Crohn's disease	0.000163	0.000694	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—IL6—Crohn's disease	0.000163	0.000694	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—UBE2D1—Crohn's disease	0.000162	0.000688	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—IL6—Crohn's disease	0.000162	0.000688	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—IL6—Crohn's disease	0.00016	0.000682	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—IL6—Crohn's disease	0.00016	0.000679	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—STAT3—Crohn's disease	0.000159	0.000677	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—RIPK2—Crohn's disease	0.000157	0.000668	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—ITGA4—Crohn's disease	0.000157	0.000668	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—SOCS1—Crohn's disease	0.000154	0.000656	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GPX4—Crohn's disease	0.000154	0.000655	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—ICAM1—Crohn's disease	0.000153	0.000652	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL3—Crohn's disease	0.000153	0.000651	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000153	0.000651	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—MTMR3—Crohn's disease	0.000152	0.000649	CbGpPWpGaD
Temsirolimus—MTOR—Disease—UBE2D1—Crohn's disease	0.000149	0.000636	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GCKR—Crohn's disease	0.000149	0.000632	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—RASGRP1—Crohn's disease	0.000148	0.00063	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD79A—Crohn's disease	0.000148	0.000628	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—TAB1—Crohn's disease	0.000145	0.000616	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—Crohn's disease	0.000145	0.000615	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—NOD2—Crohn's disease	0.000142	0.000605	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PLA2G4F—Crohn's disease	0.000135	0.000576	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—SOCS1—Crohn's disease	0.000134	0.00057	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—SMAD3—Crohn's disease	0.000133	0.000566	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCR6—Crohn's disease	0.000132	0.000561	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—TYK2—Crohn's disease	0.00013	0.000552	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	0.000127	0.000542	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—TYK2—Crohn's disease	0.000124	0.000527	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—JAK2—Crohn's disease	0.000124	0.000526	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL2RA—Crohn's disease	0.000123	0.000524	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	0.000121	0.000516	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL18—Crohn's disease	0.000121	0.000514	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—RBX1—Crohn's disease	0.000119	0.000508	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—FADS1—Crohn's disease	0.000119	0.000505	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—IL6—Crohn's disease	0.000119	0.000504	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—JAK2—Crohn's disease	0.000118	0.000503	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CD4—Crohn's disease	0.000117	0.000499	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PTGER4—Crohn's disease	0.000116	0.000494	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—MTMR3—Crohn's disease	0.000115	0.000489	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD4—Crohn's disease	0.000113	0.000479	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CD4—Crohn's disease	0.000112	0.000477	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—PTGS2—Crohn's disease	0.000111	0.000473	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GPX4—Crohn's disease	0.000111	0.000473	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—IL6—Crohn's disease	0.000111	0.000473	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—MTMR3—Crohn's disease	0.000108	0.000461	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GCKR—Crohn's disease	0.000107	0.000457	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL2RA—Crohn's disease	0.000107	0.000456	CbGpPWpGaD
Temsirolimus—MTOR—Disease—SMAD3—Crohn's disease	0.000107	0.000455	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—UBE2D1—Crohn's disease	0.000105	0.000445	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—RIPK2—Crohn's disease	0.000101	0.000432	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CRP—Crohn's disease	0.000101	0.00043	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL3—Crohn's disease	9.89e-05	0.000421	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—TLR4—Crohn's disease	9.69e-05	0.000412	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—RASGRP1—Crohn's disease	9.57e-05	0.000407	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—ICAM1—Crohn's disease	9.29e-05	0.000395	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—FADS1—Crohn's disease	8.96e-05	0.000381	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TYK2—Crohn's disease	8.68e-05	0.000369	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—STAT3—Crohn's disease	8.68e-05	0.000369	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SOCS1—Crohn's disease	8.67e-05	0.000369	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—FADS1—Crohn's disease	8.45e-05	0.000359	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GPX4—Crohn's disease	8.39e-05	0.000357	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	8.34e-05	0.000355	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—JAK2—Crohn's disease	8.28e-05	0.000352	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	8.19e-05	0.000349	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GCKR—Crohn's disease	8.1e-05	0.000345	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GPX4—Crohn's disease	7.91e-05	0.000336	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GCKR—Crohn's disease	7.64e-05	0.000325	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CXCL8—Crohn's disease	7.56e-05	0.000322	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—TYK2—Crohn's disease	7.55e-05	0.000321	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SMAD3—Crohn's disease	7.48e-05	0.000318	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—JAK2—Crohn's disease	7.2e-05	0.000306	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—MTMR3—Crohn's disease	7.09e-05	0.000302	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IFNG—Crohn's disease	7.07e-05	0.000301	CbGpPWpGaD
Temsirolimus—MTOR—Disease—TYK2—Crohn's disease	6.97e-05	0.000297	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL2RA—Crohn's disease	6.93e-05	0.000295	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD4—Crohn's disease	6.83e-05	0.000291	CbGpPWpGaD
Temsirolimus—MTOR—Disease—JAK2—Crohn's disease	6.65e-05	0.000283	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—IL6—Crohn's disease	6.34e-05	0.00027	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL1B—Crohn's disease	6.31e-05	0.000268	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CD4—Crohn's disease	6.31e-05	0.000268	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PTGS2—Crohn's disease	6.26e-05	0.000266	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—STAT3—Crohn's disease	6.08e-05	0.000259	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—IL6—Crohn's disease	6.06e-05	0.000258	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—FADS1—Crohn's disease	5.52e-05	0.000235	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	5.51e-05	0.000234	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—STAT3—Crohn's disease	5.29e-05	0.000225	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GPX4—Crohn's disease	5.17e-05	0.00022	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GCKR—Crohn's disease	4.99e-05	0.000212	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TYK2—Crohn's disease	4.88e-05	0.000208	CbGpPWpGaD
Temsirolimus—MTOR—Disease—STAT3—Crohn's disease	4.88e-05	0.000208	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ALB—Crohn's disease	4.73e-05	0.000201	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—JAK2—Crohn's disease	4.66e-05	0.000198	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CXCL8—Crohn's disease	4.25e-05	0.000181	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL6—Crohn's disease	4.25e-05	0.000181	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PTGS2—Crohn's disease	4.14e-05	0.000176	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL6—Crohn's disease	3.69e-05	0.000157	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—STAT3—Crohn's disease	3.42e-05	0.000145	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ALB—Crohn's disease	3.42e-05	0.000145	CbGpPWpGaD
Temsirolimus—MTOR—Disease—IL6—Crohn's disease	3.41e-05	0.000145	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PTGS2—Crohn's disease	2.99e-05	0.000127	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ALB—Crohn's disease	2.58e-05	0.00011	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ALB—Crohn's disease	2.43e-05	0.000103	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL6—Crohn's disease	2.39e-05	0.000102	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PTGS2—Crohn's disease	2.26e-05	9.6e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PTGS2—Crohn's disease	2.13e-05	9.05e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ALB—Crohn's disease	1.59e-05	6.76e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PTGS2—Crohn's disease	1.39e-05	5.92e-05	CbGpPWpGaD
